Balance Sheet

Assets

+93%

+216%

10Y

Currency: JPY

	Mar-2002	Mar-2003	Mar-2004	Mar-2005	Mar-2006	Mar-2007	Mar-2008	Mar-2009	Mar-2010	Mar-2011	Mar-2012	Mar-2013	Mar-2014	Mar-2015	Mar-2016	Mar-2017	Mar-2018	Mar-2019	Mar-2020	Mar-2021	Mar-2022	Mar-2023	Mar-2024	Mar-2025
Assets
Cash & Cash Equivalents	1 203	2 055	5 317	7 705	6 325	7 020	6 095	8 522	9 637	8 087	6 606	6 787	9 724	7 276	4 918	7 419	5 313	5 142	5 250	7 231	6 629	10 533	10 275	12 032
Cash Equivalents	1 203	2 055	5 317	7 705	6 325	7 020	6 095	8 522	9 637	8 087	6 606	6 787	9 724	7 276	4 918	7 419	5 313	5 142	5 250	7 231	6 629	10 533	10 275	12 032
Short-Term Investments	5	10	5	1 295	1 371	160	353	404	710	1 042	111	0	28	0	24	28	0	0	0	56	368	0	337	0
Total Receivables	1 332	1 033	1 109	1 067	1 332	2 098	1 924	2 117	2 265	2 048	2 263	2 420	2 739	3 119	3 099	2 839	2 547	1 914	2 535	2 952	3 499	4 694	5 723	6 512
Accounts Receivables	1 332	1 033	1 109	1 067	1 332	2 098	1 924	2 117	2 265	2 048	2 263	2 420	2 739	3 119	3 099	2 839	2 547	1 914	2 535	2 952	3 499	4 694	5 723	6 512
Other Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Inventory	4 571	5 545	4 826	4 438	5 808	6 682	8 219	7 824	7 949	7 482	6 084	4 452	5 366	7 593	7 315	6 966	6 439	3 600	4 032	4 071	4 359	7 329	12 373	12 618
Other Current Assets	285	254	194	554	717	749	850	959	1 222	902	738	831	893	1 022	949	894	838	1 011	594	470	1 279	1 343	2 130	1 777
Total Current Assets	7 395	8 898	11 450	15 059	15 554	16 709	17 441	19 826	21 782	19 560	15 803	14 489	18 750	19 011	16 306	18 146	15 138	11 666	12 410	14 780	16 134	23 900	30 838	32 940
PP&E Net	6 568	7 140	7 201	8 348	11 848	16 048	17 967	18 779	18 409	17 442	16 719	17 097	19 205	19 543	19 894	17 105	14 654	13 687	13 700	12 898	13 156	18 879	26 358	34 833
PP&E Gross	6 568	7 140	7 201	8 348	11 848	16 048	17 967	18 779	18 409	17 442	16 719	17 097	19 205	19 543	19 894	17 105	14 654	13 687	13 700	12 898	13 156	18 879	26 358	34 833
Accumulated Depreciation	3 408	4 083	4 566	5 225	5 781	6 866	8 347	9 334	11 075	12 280	13 547	15 033	16 951	18 744	19 704	19 945	19 999	18 268	18 388	19 118	19 579	23 441	23 257	24 966
Intangible Assets	103	110	112	333	359	396	327	307	199	157	107	102	206	195	342	371	289	93	194	214	212	261	225	219
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1 439	1 934	1 884
Note Receivable	29	38	33	43	41	58	83	90	95	101	97	77	71	70	0	1 060	1 044	1 034	455	38	37	35	33	35
Long-Term Investments	152	335	512	348	1 281	1 236	1 260	296	408	578	657	851	1 301	1 426	10 442	19 074	26 070	27 619	12 008	8 287	7 080	11 980	15 236	19 762
Other Long-Term Assets	198	167	226	353	626	805	1 025	817	1 004	808	528	378	373	307	192	498	299	231	235	756	2 693	749	1 679	2 744
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1 439	1 934	1 884
Total Assets	14 446 N/A	16 687 +16%	19 533 +17%	24 485 +25%	29 708 +21%	35 253 +19%	38 103 +8%	40 115 +5%	41 899 +4%	38 648 -8%	33 910 -12%	32 995 -3%	39 906 +21%	40 552 +2%	48 241 +19%	56 253 +17%	57 493 +2%	54 329 -6%	39 002 -28%	36 972 -5%	39 313 +6%	57 242 +46%	76 302 +33%	92 417 +21%
Liabilities
Accounts Payable	425	300	143	145	176	166	210	230	200	122	67	105	57	73	153	87	85	37	119	95	65	420	461	461
Accrued Liabilities	104	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	2 470	1 976	4 502	4 318	5 864	6 940	7 920	2 000	0	17	4 100	200	3 100
Current Portion of Long-Term Debt	1 989	1 765	742	1 930	1 935	2 492	2 271	3 494	5 065	5 930	6 381	6 768	6 332	6 330	6 225	5 959	4 790	3 635	4 198	3 665	3 069	4 994	7 770	8 810
Other Current Liabilities	5 757	7 137	6 803	7 442	9 143	9 840	11 140	10 738	9 902	8 699	7 688	7 292	7 566	8 420	8 800	7 766	8 188	6 176	6 634	8 156	10 223	11 497	15 137	16 885
Total Current Liabilities	8 276	9 201	7 688	9 517	11 254	12 499	13 621	14 462	15 167	14 751	14 136	16 635	15 931	19 325	19 496	19 676	20 003	17 768	12 951	11 916	13 374	21 012	23 568	29 256
Long-Term Debt	4 673	4 850	4 288	8 002	6 513	10 175	11 511	16 365	16 924	15 885	15 186	13 481	13 394	11 517	12 005	11 298	7 409	4 603	8 925	9 199	6 196	9 837	18 361	22 696
Deferred Income Tax	0	0	0	54	59	49	1	1	8	26	15	19	15	10	204	2 693	3 775	3 453	726	0	0	0	85	236
Minority Interest	0	0	0	3	4	83	86	70	72	59	59	68	82	27	28	22	57	69	94	104	162	147	46	63
Other Liabilities	227	162	88	202	70	66	12	7	0	121	508	77	50	55	61	112	91	28	18	19	20	34	128	143
Total Liabilities	13 176 N/A	14 214 +8%	12 064 -15%	17 773 +47%	17 891 +1%	22 872 +28%	25 231 +10%	30 906 +22%	32 171 +4%	30 841 -4%	29 904 -3%	30 280 +1%	29 473 -3%	30 936 +5%	31 794 +3%	33 802 +6%	31 335 -7%	25 920 -17%	22 714 -12%	21 238 -6%	19 752 -7%	31 030 +57%	42 188 +36%	52 394 +24%
Equity
Common Stock	320	1 057	3 353	3 353	5 391	5 391	5 391	5 391	5 391	5 391	5 391	5 391	9 061	9 061	9 061	9 679	9 679	9 679	9 679	9 679	9 679	9 679	9 679	9 679
Retained Earnings	915	668	511	144	45	486	983	571	1 005	887	4 294	5 447	6 202	7 563	7 308	8 244	12 059	10 083	2 489	3 854	10 196	13 766	17 216	20 088
Additional Paid In Capital	0	751	4 035	4 035	6 073	6 073	6 073	6 073	6 073	6 073	6 073	6 073	9 744	9 744	9 744	10 362	10 362	10 362	5 197	2 307	2 307	2 307	2 358	2 358
Unrealized Security Profit/Loss	0	104	7	20	33	38	13	2	3	5	4	108	102	202	0	12 337	19 790	20 520	6 095	2 096	171	2 597	3 644	6 032
Treasury Stock	0	0	0	0	0	0	0	673	864	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1
Other Equity	35	107	437	551	274	393	438	2 156	1 882	2 766	3 168	3 411	2 272	1 827	1 249	1 683	1 614	2 069	2 193	2 202	2 792	2 136	1 217	1 867
Total Equity	1 271 N/A	2 473 +95%	7 469 +202%	6 712 -10%	11 817 +76%	12 381 +5%	12 872 +4%	9 209 -28%	9 728 +6%	7 806 -20%	4 006 -49%	2 715 -32%	10 433 +284%	9 617 -8%	16 447 +71%	22 451 +37%	26 159 +17%	28 409 +9%	16 288 -43%	15 734 -3%	19 561 +24%	26 212 +34%	34 114 +30%	40 023 +17%
Total Liabilities & Equity	14 446 N/A	16 687 +16%	19 533 +17%	24 485 +25%	29 708 +21%	35 253 +19%	38 103 +8%	40 115 +5%	41 899 +4%	38 648 -8%	33 910 -12%	32 995 -3%	39 906 +21%	40 552 +2%	48 241 +19%	56 253 +17%	57 493 +2%	54 329 -6%	39 002 -28%	36 972 -5%	39 313 +6%	57 242 +46%	76 302 +33%	92 417 +21%
Shares Outstanding
Common Shares Outstanding	32	32	32	32	34	34	34	33	33	34	34	34	40	40	40	42	42	42	42	42	42	42	42	42

Income Statement Balance Sheet Cash Flow Statement

Shin Nippon Biomedical Laboratories Ltd
F:YB3

Balance Sheet

Balance Sheet Decomposition
Shin Nippon Biomedical Laboratories Ltd

Balance Sheet
Shin Nippon Biomedical Laboratories Ltd

See Also

Company

Help

Tools

Stocks

Shin Nippon Biomedical Laboratories Ltd F:YB3

Balance Sheet

Balance Sheet Decomposition Shin Nippon Biomedical Laboratories Ltd

Balance Sheet Shin Nippon Biomedical Laboratories Ltd

See Also

Company

Help

Tools

Stocks

Shin Nippon Biomedical Laboratories Ltd
F:YB3

Balance Sheet Decomposition
Shin Nippon Biomedical Laboratories Ltd

Balance Sheet
Shin Nippon Biomedical Laboratories Ltd